The role of RAS in the pathogenesis of preeclampsia

Current Hypertension Reports

Volumn 8, Issue 2, 2006, Pages 144-152

  Shah, Dinesh M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1B RECEPTOR; ANGIOTENSIN II; ANGIOTENSINOGEN; AUTOANTIBODY; BRADYKININ B2 RECEPTOR; INTERLEUKIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1; NORADRENALIN; PLACENTAL GROWTH FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PRAZOSIN; PROLACTIN; RENIN; VASCULOTROPIN RECEPTOR;

ANTIBODY PRODUCTION; AUTOIMMUNITY; CLINICAL FEATURE; COMA; DIMERIZATION; DISEASE ASSOCIATION; DISEASE MODEL; ENDOTHELIAL DYSFUNCTION; FEMALE; FETOPLACENTAL UNIT; FIBRIN FORMATION; GENE EXPRESSION; HUMAN; HYPERTENSION; INTRAHEPATIC CHOLESTASIS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PREECLAMPSIA; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; SYSTEMIC CIRCULATION; THROMBOCYTE ACTIVATION; TRANSGENE; TRANSGENIC ANIMAL; VASCULAR LESION;

ANGIOTENSIN II; ANIMALS; FEMALE; HUMANS; HYPERTENSION, RENOVASCULAR; MICE; MICE, TRANSGENIC; PRE-ECLAMPSIA; PREGNANCY; RENIN-ANGIOTENSIN SYSTEM;

EID: 33744485271     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-006-0011-1     Document Type: Review

References (83)

1. Morgan T, Craven C, Lalouel JM, Ward K: Angiotensinogen Thr235 variant is associated with abnormal physiologic change of the uterine spiral arteries in first-trimester decidua. Am J Obstet Gynecol 1999, 180:95-102.
2. Zoumakis E, Margioris AN, Stournaras C, et al.: Corticotrophin-releasing hormone (CRH) interacts with inflammatory prostaglandins and interleukins and affects the decidualization of human endometrial stroma. Mol Hum Reprod 2000, 6:344-351.
3. Nielsen AH, Schauser KH, Poulsen K: Current topic: the uteroplacental renin-angiotensin system. Placenta 2000, 21:468-477.
4. Agarwal M, Lynn KL, Richards AM, Nicholls MG: Hyponatremic-hypertensive syndrome with renal ischemia: an underrecognized disorder. Hypertension 1999, 33:1020-1024.
5. Symonds EM: Renin and reproduction. Am J Obstet Gynecol 1988, 158:754-761.
6. Brosens I, Dixon HG: The anatomy of the maternal side of the placenta. J Obstet Gynaecol Br Commonw 1966, 73:357-363.
7. Ramsey E, Harris JWS: Comparison of uteroplacental vasculature and circulation in rhesus monkey and man. Contrib Embryol Carnegie Inst Wash 1966, 38:59.
8. Symonds EM, Stanley MA, Skinner SL: Production of renin by in vitro cultures of human chorion and uterine muscle. Nature 1968, 217:1152-1153.
9. Ihara Y, Taii S, Mori T: Expression of renin and angiotensinogen genes in the human placental tissues. Endocrinol Jpn 1987, 34:887-896.
10. Li C, Yu Z, Shah DM: Authenticity and cellular localization of prorenin in human placenta (abstract). J Soc Gynecol Investig 2001, 8(Suppl1):207A.
11. Li X, Shams M, Zhu J, et al.: Cellular localization of AT1 receptor mRNA and protein in normal placenta and its reduced expression in intrauterine growth restriction. Angiotensin II stimulates the release of vasorelaxants. J Clin Invest 1998, 101:442-454.
12. Hariyama Y, Itakura A, Okamura M, et al.: Placental aminopeptidase A as a possible barrier of angiotensin II between mother and fetus. Placenta 2000, 21:621-627.
13. Ito M, Itakura A, Ohno Y, et al.: Possible activation of the renin-angiotensin system in the feto-placental unit in preeclampsia. J Clin Endocrinol Metab 2002, 87:1871-1878.
14. Shaw KJ, Do YS, Kjos S, et al.: Human decidua is a major source of renin. J Clin Invest 1989, 83:2085-2092.
15. Morgan T, Craven C, Ward K: Human spiral artery renin-angiotensin system. Hypertension 1998, 32:683-687.
16. Li C, Ansari R, Yu Z, Shah D: Definitive molecular evidence of renin-angiotensin system in human uterine decidual cells. Hypertension 2000, 36:159-164.
17. Oelkers WK: Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure. Steroids 1996, 61:166-171.
18. Shah DM, Higuchi K, Inagami T, Osteen KG: Effect of progesterone on renin secretion in endometrial stromal, chorionic trophoblast, and mesenchymal monolayer cultures. Am J Obstet Gynecol 1991, 164:1145-1150.
19. Yan JS, Guo LH, Liu J, Wang H: [Modulation of the secretion of active renin in human decidual cells by progesteronel. Sheng Li Xue Bao 1999, 51:211-218.
20. Dzau VJ, Gonzalez D, Ellison K, et al.: Characterization of purified rabbit uterine renin: influence of pregnancy on uterine inactive renin. Endocrinology 1987, 120:358-364.
21. Itakura A, Mizutani S: Involvement of placental peptidases associated with renin-angiotensin systems in preeclampsia. Biochim Biophys Acta 2005, 1751:68-72.
22. Leung PS, Tsai SJ, Wallukat G, et al.: The upregulation of angiotensin II receptor AT(1) in human preeclamptic placenta. Mol Cell Endocrinol 2001, 184:95-102.
23. Kalenga MK, Thomas K, de Gasparo M, De Hertogh R: Determination of renin, angiotensin-converting enzyme and angiotensin II levels in human placenta, chorion and amnion from women with pregnancy-induced hypertension. Clin Endocrinol (Oxf) 1996, 44:429-433.
24. Skinner SL, Lumbers ER, Symonds EM: Analysis of changes in the renin-angiotensin system during pregnancy. Clin Sci 1972, 42:479-488.
25. Brown MA, Zammit VC, Mitar DA, Whitworth JA: Renin-aldosterone relationships in pregnancy-induced hypertension. Am J Hypertens 1992, 5:366-371.
26. Symonds EM, Broughton Pipkin F, Craven DJ: Changes in the renin-angiotensin system in primigravidae with hypertensive disease of pregnancy. Br J Obstet Gynaecol 1975, 82:643-650.
27. Abdul-Karim R, Assali N: Pressor response to angiotenin in pregnant and nonpregnant women. Am J Obstet Gynecol 1961, 82:246-251.
28. Gant NF, Daley GL, Chand S, et al.: A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 1973, 52:2682-2689.
29. Merrill DC, Karoly M, Chen K, et al.: Anglotensin-(1-7) in normal and preeclamptic pregnancy. Endocrine 2002, 18:239-245.
30. August P, Lenz T, Ales KL, et al.: Longitudinal study of the renin-angiotensin-aldosterone system in hypertensive pregnant women: deviations related to the development of superimposed preeclampsia. Am J Obstet Gynecol 1990, 163:1612-1621.
31. Hill PA, Fairley KF, Kincaid-Smith P, et al.: Morphologic changes in the renal glomerulus and the juxtaglomerular apparatus in human preeclampsia. J Pathol 1988, 156:291-303.
32. Brown MA, Wang J, Whitworth JA: The renin-angiotensin-aldosterone system in pre-eclampsia. Clin Exp Hypertens 1997, 19:713-726.
33. August P, Helseth G, Cook EF, Sison C: A prediction model for superimposed preeclampsia in women with chronic hypertension during pregnancy. Am J Obstet Gynecol 2004, 191:1666-1672.
34. Bachmann S, Peters J, Engler E, et al.: Transgenic rats carrying the mouse renin gene - morphological characterization of a low-renin hypertension model. Kidney Int 1992, 41:24-36.
35. Shah DM, Banu JM, Chirgwin JM, Tekmal RR: Reproductive tissue renin gene expression in preeclampsia. Hypertens Pregnancy 2000, 19:341-351.
36. Assali NS, Westersten A: Regional flow-pressure relationship in response to angiotensin in the intact dog and sheep. Circ Res 1961, 9:189-193.
37. Ferris TF, Stein JH, Kauffman J: Uterine blood flow and uterine renin secretion. J Clin Invest 1972, 51:2827-2833.
38. Cox BE, Williams CE, Rosenfeld CR: Angiotensin II indirectly vasoconstricts the ovine uterine circulation. Am J Physiol Regul Integr Comp Physiol 2000, 278: R337-R344.
39. Takimoto E, Ishida J, Sugiyama F, et al.: Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science 1996, 274:995-998.
40. Saito T, Ishida J, Takimoto-Ohnishi E, et al.: An essential role for angiotensin II type 1a receptor in pregnancy, associated hypertension with intrauterine growth retardation. FASEB J 2004, 18:388-390.
41. Samani NJ, Godfrey NP, Major JS, et al.: Kidney renin mRNA levels in the early and chronic phases of two-kidney, one clip hypertension in the rat. J Hypertens 1989, 7:105-112.
42. Abitbol MM, Pirani CL, Ober WB, et al.: Production of experimental toxemia in the pregnant dog. Obstet Gynecol 1976, 48:537-548.
43. Alexander BT, Kassab SE, Miller MT, et al.: Reduced uterine perfuslon pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. Hypertension 2001, 37:1191-1195.
44. Cavanagh D, Rao PS, Tsai CC, O'Connor TC: Experimental toxemia in the pregnant primate. Am J Obstet Gynecol 1977, 128:75-85.
45. Combs CA, Katz MA, Kitzmiller JL, Brescia RJ: Experimental preeclampsia produced by chronic constriction of the lower aorta: validation with longitudinal blood pressure measurements in conscious rhesus monkeys. Am J Obstet Gynecol 1993, 169:215-223.
46. Chesley LC, Talledo E, Bohler CS, Zuspan FP: Vascular reactivity to angiotensin II and norepinephrine in pregnant women. Am J Obstet Gynecol 1965, 91:837-842.
47. Schobel HP, Fischer T, Heuszer K, et al.: Preeclampsia - a state of sympathetic overactivity. N Engl J Med 1996, 335:1480-1485.
48. Fitzgerald DJ, Rocki W, Murray R, et al.: Thromboxane A2 synthesis in pregnancy-induced hypertension. Lancet 1990, 335:751-754.
49. Furuhashi N, Tsujiei M, Kimura H; et al.: Plasma renin activity, angiotensin II, prostacyclin and thromboxane A2 concentrations in 139 preeclamptic patients. Tohoku J Exp Med 1990, 162:235-241.
50. Lindheimer MD, Katz AI, Nolten WE, et al.: Sodium and mineralocorticoids In normal and abnormal pregnancy. Adv Nephrol Necker Hosp 1977, 7:33-59.
51. Lopatin DA, Ailamazian EK, Dmitrieva RI, et al.: Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia. J Hypertens 1999, 17:1179-1187.
52. Maxwell CV, Tao QF, Seely EW, et al.: Regulation of the sodium pump in pregnancy-related tissues in preeclampsia. Am J Obstet Gynecol 1998, 179:28-34.
53. AbdAlla S, Lother H, el Massiery A, Quitterer U: Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med 2001, 7:1003-1009.
54. Wallukat G, Homuth V, Fischer T, et al.: Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 1999, 103:945-952.
55. Dechend R, Viedt C, Muller DN, et al.: AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase. Circulation 2003, 107:1632-1639.
56. Thway TM, Shlykov SG, Day MC, et al.: Antibodies from preeclamptic patients stimulate Increased intracellular Ca2+ mobilization through angiotensin receptor activation. Circulation 2004, 110:1612-1619.
57. Bobst SM, Day MC, Gilstrap LC 3rd, et al.: Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion. Am J Hypertens 2005, 18:330-336.
58. Clark DE, Smith SK, He Y, et al.: A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod 1998, 59:1540-1548.
59. He Y, Smith SK, Day KA, et al.: Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity. Mol Endocrinol 1999, 13:537-545.
60. Maynard SE, Min JY, Merchan J, et al.: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003, 111:649-658.
61. Zhou Y, McMaster M, Woo K, et al.: Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 2002, 160:1405-1423.
62. Khatun S, Kanayama N, Sato E, et al.: Eclamptic plasma stimulates norepinephrine release in cultured sympathetic nerve. Hypertension 1998, 31:1343-1349.
63. Nova A, Sibai BM, Barton JR, et al.: Maternal plasma level of endothelin is increased in preeclampsia. Am J Obstet Gynecol 1991, 165:724-727.
64. Shah D, Frazer M, Badr KF: Circulating endothelin-1 is not increased in severe preeclampsia. J Matern Fetal Med 1992, 1:177-180.
65. Taylor RN, Varma M, Teng NN, Roberts JM: Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab 1990, 71:1675-1677.
66. Hubel CA: Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 1999, 222:222-235.
67. McIntyre M, Bohr DF, Dominiczak AF: Endothelial function in hypertension: the role of superoxide anion. Hypertension 1999, 34:539-545.
68. Pascoal IF, Lindheimer MD, Nalbantian-Brandt C, Umans JG: Preeclampsia selectively impairs endothelium-dependent relaxation and leads to oscillatory activity in small omental arteries. J Clin Invest 1998, 101:464-470.
69. Roggensack AM, Zhang Y, Davidge ST: Evidence for peroxynitrite formation in the vasculature of women with preeclampsia. Hypertension 1999, 33:83-89.
70. Platts JK, Meadows P, Jones R, Harvey JN: The relation between tissue kallikrein excretion rate, aldosterone and glomerular filtration rate in human pregnancy. BJOG 2000, 107:278-281.
71. McKinley MJ, Albiston AL, Allen AM, et al.: The brain renin-angiotensin system: location and physiological roles. Int J Biochem Cell Biol 2003, 35:901-918.
72. Belfort MA, Grunewald C, Saade GR, et al.: Preeclampsia may cause both overperfusion and underperfusion of the brain: a cerebral perfusion based model. Acta Obstet Gynecol Scand 1999, 78:586-591.
73. Takao M, Kobari M, Tanahashi N, et al.: Dilatation of cerebral parenchymal vessels mediated by angiotensin type 1 receptor in cats. Neurosci Lett 2002, 318:108-112.
74. Zeek PM, Assali NS: Vascular changes in the decidua associated with eclamptogenic toxemia of pregnancy. Am J Clin Pathol 1950, 20:1099-1109.
75. De Wolf F, Brosens I, Robertson WB: Ultrastructure of uteroplacental arteries. Contrib Gynecol Obstet 1982, 9:86-99.
76. Kintscher U, Wakino S, Kim S, et al.: Angiotensin II induces migration and Pyk2/paxillin phosphorylation of human monocytes. Hypertension 2001, 37:587-593.
77. Capers Qt, Alexander RW, Lou P, et al.: Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats. Hypertension 1997, 30:1397-1402.
78. Bush E, Maeda N, Kuziel WA, et al.: CC chemokine receptor 2 is required for macrophage infiltration and vascular hypertrophy in angiotensin II-induced hypertension. Hypertension 2000, 36:360-363.
79. Nemerson Y: Tissue factor and hemostasis. Blood 1988, 71:1-8.
80. Dechend R, Homuth V, Wallukat G, et al.: AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation 2000, 101:2382-2387.
81. Brown NJ, Vaughan DE: Prothrombotic effects of angiotensin. Adv Intern Med 2000, 45:419-429.
82. Napoleone E, Di Santo A, Camera M, et al.: Angiotensin-converting enzyme inhibitors downregulate tissue factor synthesis in monocytes. Circ Res 2000, 86:139-143.
83. Shah DM: Role of renin angiotensin system in the pathogenesis of preeclampsia. Am J Physiol Renal Physiol 2005, 288:F614-F625